Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Temafloxacin disk potency and tentative interpretive criteria for susceptibility tests.

Literature DB >> 2592548

Temafloxacin disk potency and tentative interpretive criteria for susceptibility tests.

Abstract

Temafloxacin disk susceptibility test criteria were evaluated by testing 697 bacterial isolates. Either 5- or 10-micrograms disks could be used satisfactorily. A 5-micrograms temafloxacin disk with zone size breakpoints of less than or equal to 12 mm for resistance (MIC, greater than 4.0 micrograms/ml) and greater than 16 mm for susceptibility (MIC, less than or equal to 2.0 micrograms/ml) is recommended.

Entities: Chemical

Mesh：

Substances：

Year: 1989 PMID： 2592548 PMCID： PMC267145 DOI： 10.1128/jcm.27.12.2861-2863.1989

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

9 in total

1. Tentative disk diffusion susceptibility interpretive criteria for pefloxacin.

Authors: P C Fuchs; A L Barry; R N Jones; C Thornsberry
Journal: J Clin Microbiol Date: 1986-09 Impact factor: 5.948

2. Proposed disk diffusion susceptibility criteria for ofloxacin.

Authors: P C Fuchs; A L Barry; R N Jones; C Thornsberry
Journal: J Clin Microbiol Date: 1985-08 Impact factor: 5.948

3. Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limits.

Authors: P C Fuchs; A L Barry; R N Jones; C Thornsberry
Journal: Diagn Microbiol Infect Dis Date: 1985-05 Impact factor: 2.803

4. RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria.

Authors: P C Fuchs; R N Jones; A L Barry; L W Ayers; T L Gavan; E H Gerlach; C Thornsberry
Journal: Diagn Microbiol Infect Dis Date: 1987-05 Impact factor: 2.803

5. Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.

Authors: A L Barry; R N Jones
Journal: Eur J Clin Microbiol Date: 1987-04 Impact factor: 3.267

6. In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.

Authors: N X Chin; V M Figueredo; A Novelli; H C Neu
Journal: Eur J Clin Microbiol Infect Dis Date: 1988-02 Impact factor: 3.267

7. Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.

Authors: P C Fuchs; R N Jones; A L Barry; T L Gavan
Journal: J Clin Microbiol Date: 1989-01 Impact factor: 5.948

8. Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.

Authors: D J Hardy; R N Swanson; D M Hensey; N R Ramer; R R Bower; C W Hanson; D T Chu; P B Fernandes
Journal: Antimicrob Agents Chemother Date: 1987-11 Impact factor: 5.191

9. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.

Authors: A L Barry; R N Jones
Journal: J Antimicrob Chemother Date: 1989-04 Impact factor: 5.790

9 in total

4 in total

1. Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium.

Authors: M E Erwin; R N Jones
Journal: J Clin Microbiol Date: 1992-05 Impact factor: 5.948